6.
Avvakumov G, Walker J, Xue S, Allali-Hassani A, Asinas A, Nair U
. Two ZnF-UBP domains in isopeptidase T (USP5). Biochemistry. 2012; 51(6):1188-98.
PMC: 8391072.
DOI: 10.1021/bi200854q.
View
7.
Luo X, Xi J, Liu Z, Long Y, Li L, Luo Z
. Proinflammatory Effects of Ubiquitin-Specific Protease 5 (USP5) in Rheumatoid Arthritis Fibroblast-Like Synoviocytes. Mediators Inflamm. 2020; 2020:8295149.
PMC: 7085372.
DOI: 10.1155/2020/8295149.
View
8.
Okada K, Ye Y, Taniguchi K, Yoshida A, Akiyama T, Yoshioka Y
. Vialinin A is a ubiquitin-specific peptidase inhibitor. Bioorg Med Chem Lett. 2013; 23(15):4328-31.
DOI: 10.1016/j.bmcl.2013.05.093.
View
9.
Qian G, Zhu L, Huang C, Liu Y, Ren Y, Ding Y
. Ubiquitin specific protease 5 negatively regulates the IFNs-mediated antiviral activity via targeting SMURF1. Int Immunopharmacol. 2020; 87:106763.
DOI: 10.1016/j.intimp.2020.106763.
View
10.
Ban T, Sato G, Nishiyama A, Akiyama A, Takasuna M, Umehara M
. Lyn Kinase Suppresses the Transcriptional Activity of IRF5 in the TLR-MyD88 Pathway to Restrain the Development of Autoimmunity. Immunity. 2016; 45(2):319-32.
DOI: 10.1016/j.immuni.2016.07.015.
View
11.
Duan T, Feng Y, Du Y, Xing C, Chu J, Ou J
. USP3 plays a critical role in the induction of innate immune tolerance. EMBO Rep. 2023; 24(12):e57828.
PMC: 10702844.
DOI: 10.15252/embr.202357828.
View
12.
Kapuria V, Peterson L, Showalter H, Kirchhoff P, Talpaz M, Donato N
. Protein cross-linking as a novel mechanism of action of a ubiquitin-activating enzyme inhibitor with anti-tumor activity. Biochem Pharmacol. 2011; 82(4):341-9.
DOI: 10.1016/j.bcp.2011.05.012.
View
13.
Xie X, Matsumoto S, Endo A, Fukushima T, Kawahara H, Saeki Y
. Deubiquitylases USP5 and USP13 are recruited to and regulate heat-induced stress granules through their deubiquitylating activities. J Cell Sci. 2018; 131(8).
DOI: 10.1242/jcs.210856.
View
14.
Harrigan J, Jacq X, Martin N, Jackson S
. Deubiquitylating enzymes and drug discovery: emerging opportunities. Nat Rev Drug Discov. 2017; 17(1):57-78.
PMC: 7097658.
DOI: 10.1038/nrd.2017.152.
View
15.
Dayal S, Sparks A, Jacob J, Allende-Vega N, Lane D, Saville M
. Suppression of the deubiquitinating enzyme USP5 causes the accumulation of unanchored polyubiquitin and the activation of p53. J Biol Chem. 2008; 284(8):5030-41.
PMC: 2696100.
DOI: 10.1074/jbc.M805871200.
View
16.
Wang C, Chen G, Chien C
. The deubiquitinase Leon/USP5 regulates ubiquitin homeostasis during Drosophila development. Biochem Biophys Res Commun. 2014; 452(3):369-75.
DOI: 10.1016/j.bbrc.2014.08.069.
View
17.
Chen Q, Su J, Chen X
. Role of ubiquitin-specific protease 5 in the inflammatory response of chronic periodontitis. Oral Dis. 2021; 29(3):1234-1241.
DOI: 10.1111/odi.14114.
View
18.
Wang S, Juan J, Zhang Z, Du Y, Xu Y, Tong J
. Inhibition of the deubiquitinase USP5 leads to c-Maf protein degradation and myeloma cell apoptosis. Cell Death Dis. 2017; 8(9):e3058.
PMC: 5636991.
DOI: 10.1038/cddis.2017.450.
View
19.
Shang Y, Smith S, Hu X
. Role of Notch signaling in regulating innate immunity and inflammation in health and disease. Protein Cell. 2016; 7(3):159-74.
PMC: 4791423.
DOI: 10.1007/s13238-016-0250-0.
View
20.
Zheng Y, Wang L, Niu X, Guo Y, Zhao J, Li L
. EOAI, a ubiquitin-specific peptidase 5 inhibitor, prevents non-small cell lung cancer progression by inducing DNA damage. BMC Cancer. 2023; 23(1):28.
PMC: 9826599.
DOI: 10.1186/s12885-023-10506-0.
View